These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981 [TBL] [Abstract][Full Text] [Related]
24. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer. Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549 [TBL] [Abstract][Full Text] [Related]
25. Association between germline HOXB13 G84E mutation and risk of prostate cancer. Akbari MR; Trachtenberg J; Lee J; Tam S; Bristow R; Loblaw A; Narod SA; Nam RK J Natl Cancer Inst; 2012 Aug; 104(16):1260-2. PubMed ID: 22781434 [TBL] [Abstract][Full Text] [Related]
26. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours. FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341 [TBL] [Abstract][Full Text] [Related]
27. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey. Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062 [TBL] [Abstract][Full Text] [Related]
28. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls. Shang Z; Zhu S; Zhang H; Li L; Niu Y Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396 [No Abstract] [Full Text] [Related]
29. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer. Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555 [TBL] [Abstract][Full Text] [Related]
30. Germline mutations in HOXB13 and prostate-cancer risk. Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224 [TBL] [Abstract][Full Text] [Related]
31. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C; Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858 [TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]